Abstract The current study addresses the effects of a high-fat diet on liver and brain fatty acid compositions and the interaction of that diet with diabetes in a type 1 mouse model. Adult, male, normal and streptozotocin-induced diabetic C57BL/6 mice were fed standard (14 % kcal from fat) or high-fat (54 % kcal from fat, hydrogenated vegetable shortening and corn oil) diets for 8 weeks. Liver and whole brain total phospholipid fatty acid compositions were then determined by TLC/GC. In the liver of nondiabetic mice, the high-fat diet increased the percentages of 18:1n-9, 20:4n-6, and 22:5n-6 and decreased 18:2n-6 and 22:6n-3. Diabetes increased 16:0 in liver, and decreased 18:1n-7 and 20:4n-6. The effects of the high-fat diet on liver phospholipids in diabetic mice were similar to those in non-diabetic mice, or were of smaller magnitude. In the brain, the high-fat diet increased 18:0 and 20:4n-6 of nondiabetic, but not diabetic mice. Brain 22:5n-6 acid was increased by the high-fat diet in both non-diabetic and diabetic mice, but this increase was smaller in diabetic mice. Diabetes alone did not alter the percentage of any individual fatty acid in brain. This indicates that the effects of a high-fat diet on liver and brain phospholipid fatty acid compositions are partially attenuated by concomitant hyperglycemia with hypoinsulinemia.
Introduction
A high-fat diet is associated with a variety of significant health concerns. Most notably, obesity and insulin resistance, key factors in metabolic syndrome, are associated with high intake of fats, particularly saturated fats, and the consequent high caloric intake [1] [2] [3] [4] . Heart disease, kidney disease, and cancer are also associated with high dietary fat content [5] [6] [7] . In addition, epidemiologic evidence suggests diet may also affect Alzheimer's risk, with the Mediterranean diet conferring lower risk than the higher fat Western diet [8] . There is also a high comorbidity of depression with metabolic syndrome [9] . Thus, the effects of high dietary fat intake have potentially serious health consequences for many organ systems including the liver and brain.
Diabetes, whether type 1 or type 2, is associated with variety of complications related to poor glycemic control including effects on the nervous system and liver. At least some of these complications, such as peripheral vascular disease and neuropathy, appear to be augmented by high dietary fat intake [10, 11] . Liver disease also appears to be a complication of both type 1 and type 2 diabetes [12] [13] [14] . In addition, the pathogenesis of Alzheimer's disease is associated with altered glucose utilization and insulin resistance in the brain [15] . In fact, metabolic syndrome and type 2 diabetes may represent independent risk factors for Alzheimer's disease [16] . Although type I diabetes is not as clearly associated with Alzheimer's disease, suboptimal cognitive function, including lower verbal and full scale IQ scores, is reported [17] [18] [19] . Decreases in white and gray matter are noted as early as 12 years after diagnosis [18] . Long-term consequences include type 1 diabetic encephalopathy, which includes loss of white and gray matter, temporal lobe sclerosis, synaptic alterations, increased microvascular permeability, neuron loss, and impaired cognitive function [20, 21] . In view of these effects of diabetes on liver and brain function, it is important to examine the interaction of a highfat diet and diabetes on these organs.
Phospholipids form the lipid bilayer of cell membranes. The fatty acid composition of membrane phospholipids determines the physicochemical properties for the membrane. This influences cell function in variety ways including forming the microenvironment around membrane-bound proteins and altering the composition of lipid rafts, thus affecting their function [22, 23] . Some fatty acids, notably polyunsaturated fatty acids (PUFA) are cleaved from the membrane by phospholipases and act as signaling molecules, initiating gene transcription through nuclear receptors such as PPAR, RXR, and LXR [24] . In addition, PUFA such as arachidonic acid (ARA; 20:4n-6), eicosapentaenoic acid (EPA; 20:5n-3), and docosahexaenoic acid (DHA; 22:6n-3) are precursors for a variety of pro-or anti-inflammatory mediators such as prostaglandins, leukotrienes, resolvins, protectins, and maresins [22, [25] [26] [27] [28] [29] [30] . The fatty acid composition of membrane phospholipids varies depending on diet and physiologic state (e.g., pregnancy), and is also altered in disease states [31] [32] [33] [34] [35] [36] . Accordingly, diet, physiological state, and disease may alter cellular function in numerous ways as a result of secondary changes in membrane fatty acid composition.
This study determined the effects of a high-fat diet and the interaction of that diet with increased blood glucose levels on liver and brain phospholipid fatty acid composition. Liver was examined because of its central role in lipid and glucose homeostasis and because of its relatively high rate of phospholipid turnover, which makes it highly responsive to dietary and other manipulations [37] [38] [39] . Brain was examined because of its essential role in organismal function and because brain fatty acid composition is altered in neuropsychiatric disorders such as Alzheimer's disease and depression [34] [35] [36] . Hyperglycemia was examined independent of increased insulin levels using a mouse model of type 1 diabetes. It was hypothesized that a high fat diet would exacerbate the effect of diabetes. Contrary to our hypothesis we will show that the effects of a high-fat diet on liver and brain phospholipid fatty acid compositions are mitigated by concomitant hyperglycemia with hypoinsulinemia.
Methods
All experiments were performed in accordance with the NIH Guide for the Care and Use of Laboratory Animals [40] and were approved by the University of Kansas Medical Center Institutional Animal Care and Use Committee (protocol #2010-1873).
Animals
Male C57Bl/6 mice (7-weeks-old, n = 8 per group; Charles River, Wilmington, MA) were housed in a temperature-and humidity-controlled animal facility with a 12-h dark-light cycle (on at 06:00), given food and water ad libitum. Mice were allowed to acclimate for 1 week prior to the experimental treatments.
Diets and Diet Treatment
The Control diet was a standard laboratory chow (Teklad 8604, Teklad, Madison, WI), which had 4.7 % fat by weight and 14 % kcal from fat, 32 % kcal from protein, and 54 % kcal from carbohydrate. The High-fat diet was Teklad TD.07011, which had 29 % fat by weight and 54 % kcal from fat (comprised of hydrogenated vegetable shortening and corn oil), 21 % kcal from protein, and 24 % kcal from carbohydrate). The fatty acid composition of the diets is presented in Table 1 .
All mice were fed the Control diet during the acclimation week. Mice on the High-fat groups were fed the Highfat diet beginning 3 h after administration of streptozotocin (STZ). Mice in the Control diet groups continued to be fed the Control diet for the duration of the study.
Diabetes Induction
Diabetes was induced by a single injection of STZ (180 mg/kg, ip, in 10 mM sodium citrate, pH 4.5, SigmaAldrich, St. Louis, MO). Mice in the non-diabetic groups were injected with the vehicle (10 mM sodium citrate, pH 4.5, ip, 400 ll). Blood glucose and body weight were monitored weekly beginning 1 week after STZ treatment (glucose diagnostic reagents, Sigma-Aldrich). Mice with blood glucose levels [300 mg/dL were considered diabetic. STZ-treated mice with blood glucose levels \300 mg/dL were excluded from the study.
Sample Collection
At 8 weeks after STZ treatment, mice were deeply anesthetized with Avertin (1.25 % v/v, ip, Sigma-Aldrich) and decapitated. Blood was collected into Eppendorf tubes for preparation of serum. Serum insulin and lipids were determined using commercial kits (Wako Diagnostics, Cayman Chemical, and Alpco). Liver samples (*100 mg) and brains were collected and frozen on dry ice for determine of fatty acid composition. Tissue samples were stored at -80°C until used.
Fatty Acid Analysis
Total phospholipid fatty acid composition was determined in liver samples and the left hemisphere of each brain as previously described [41] . Phospholipids were extracted and isolated by thin layer chromatography. The band containing total phospholipids was removed and transmethylated with boron trifluoride methanol (Sigma, St. Louis, MO) to yield fatty acid methyl esters. Individual fatty acid methyl esters were separated on a Varian 3400 gas chromatograph with an SP-2330 capillary column (30 m, Supelco, Inc., Belfonte, PA), with helium used as the carrier gas. The resulting peaks were identified and quantified on the basis of peak area by comparison to authentic standards (PUFA 1 and 2 and Supelco 37 FAME mix, Supelco, Inc. and 22:5n-6, Nu-Chek Prep, Elysian, MN), corrected for response factor, and expressed as %mol of total fatty acids.
Data Analysis
Results are presented as means ± SEM. Data are reported for the individual fatty acids detected in greater than trace amounts or are otherwise of interest. Data for classes of fatty acids include those detected in trace amounts. Data were analyzed for statistically significant effects on each fatty acid measured by two-way ANOVA, with factors of diet (Control or High-fat) and Diabetes status (non-diabetic or diabetic). A significant ANOVA was followed by Tukey's test comparing all four groups (Systat, v12). An outlier identified by Systat (1 liver sample in the diabeticControl diet group) was eliminated from the final analysis. Significance was assumed at P \ 0.05.
Results

Effects of the Diet and STZ Treatments on Body Weight, and Serum Glucose, Insulin, and Lipids
Detailed data on the effects of these treatments across the 8-week observation period were previously reported [42] , and are thus summarized briefly here. At the end of the 8 week treatment period, body weights were significantly different between all groups (P \ 0.05), with non-diabetic mice fed the High-fat diet weighing 29 % more than nondiabetic mice fed the Control diet. Diabetic mice fed the High-fat diet and diabetic mice fed the Control diet weighed 9 and 25 % less than non-diabetic mice fed the Control diet. Serum insulin levels were decreased 90 and 71 %, and serum glucose levels were increased 317 and 243 %, respectively, compared to non-diabetic mice fed the Control diet. Nondiabetic mice fed the High-fat diet had increases in serum insulin and glucose concentration of 62 and 65 %, respectively compared to non-diabetic mice fed the Control diet. Minor differences in total cholesterol and LDL-cholesterol were observed between groups; however, serum triacylglycerol was 400 % higher in diabetic mice fed the High-fat diet than in non-diabetic mice fed the High-fat diet.
Effects of the Diet and STZ Treatments on Liver Phospholipid Fatty Acid Composition
In non-diabetic mice, the High-fat diet increased the percentage of 18:1n-9 by 196 % (P \ 0.001), contributing to an increase in total monounsaturated fatty acids (MUFA) of 89 % compared to those fed the Control diet (P \ 0.001) ( Table 2 ). The percentage of 20:4n-6 and 22:5n-6 also increased by 24 % (P \ 0.001) and 1,005 % (P \ 0.001), respectively. Decreases were observed for 18:2n-6 (25 %, P \ 0.001), and 22:6n-3 (67 %, P \ 0.001), which contributed to a 69 % decrease in total n-3 PUFA content (P \ 0.01) and decreases in the DHA:ARA and n-3:n-6 ratios of 72-74 % (P \ 0.001). Total PUFA content was also decreased 17 % (P \ 0.001). In addition, the ratio of 18:3n-6 to 18:2n-6 was decreased 67 % (P \ 0.001). The ratio of 18:1n-9-18:0 was increased 174 % (P \ 0.001). Diabetic mice fed the Control diet exhibited an 86 % increase in the percentage of 16:0 (P \ 0.01) and decreases in 18:1n-7 (64 %, P \ 0.05) and 20:4n-6 (18 %, P \ 0.01) compared to non-diabetic mice fed the Control diet. Together, these diabetes-induced changes in fatty acid composition contributed to increased total saturated fatty acids (SFA) (29 %, P \ 0.01), and decreases in total n-6 PUFA (14 %, P \ 0.01), total PUFA (11 %, P \ 0.01), and the PUFA:SFA ratio (32 %, P \ 0.01).
In diabetic mice fed the High-fat diet, the percentage of 20:4n-6 was increased 44 % (P \ 0.001) and 18 % (P \ 0.01) compared to diabetic and non-diabetic mice fed the Control diet, respectively, and was similar to that of non-diabetic mice fed the High-fat diet. The percentage of 22:5n-6 was 50 % lower than in non-diabetic mice fed the High-fat diet (P \ 0.001); however, the magnitude of the increase induced by the High-fat diet compared to diabetic mice fed the Control diet (970 %, P \ 0.001) was similar to the 10-fold increase produced by the High-fat diet in non-diabetic mice. In addition, the percentages of 18:1n-9 and total MUFA were increased by the High-fat diet in diabetic mice (87 and 68 %, respectively, P \ 0.001) compared to diabetic mice fed the control diet, but the magnitude of the increases produced by the High-fat diet Different from high-fat diet, non-diabetic (P \ 0.05) à Different for control diet, diabetic (P \ 0.05) by two-way ANOVA followed by Tukey's test comparing all four groups were smaller than in non-diabetic mice fed the High-fat diet (both P \ 0.01). These changes in individual fatty acids resulted in an increase in total MUFA, and decreases in total n-3 PUFA, total PUFA, and the DHA:ARA and n-3:n-6 ratios; however, the magnitude of the changes in these classes of fatty acids were smaller than those produced by the High-fat diet in non-diabetic mice. Furthermore diabetic mice fed the High-fat diet had percentages of 16:0, total SFA, 18:1n-7, 18:2n-6, total n-6 PUFA, and PUFA:SFA ratio that were not different from non-diabetic mice fed the Control diet.
Compared to diabetic mice fed the Control diet, the ratio of 18:3n-6 to 18:2n-6 in diabetic mice fed the High-fat was decreased 50 % (P \ 0.01), similar to the effects of the High-fat diet in non-diabetic mice. The ratio of 20:4n-6 to 20:3n-6 was increased 63 % (P \ 0.001), again similar to the effect of the High-fat diet in non-diabetic mice. The ratio of 18:1n-9 to 18:0 was increased 56 % (P \ 0.01). This increase in the ratio of 18:1n-9 to 18:0 was significantly smaller than that produced by the High-fat diet in non-diabetic mice (P \ 0.001).
Effects of the Diet and STZ Treatments on Brain Phospholipid Fatty Acid Composition
In non-diabetic mice, the High-fat diet increased 18:0 by 8 % (P \ 0.05) compared to those fed the Control diet ( Table 3 ). The percentages of 20:4n-6 and 22:5n-6 increased 18 % (P \ 0.01) and 645 % (P \ 0.001), respectively, contributing to an increase in total n-6 PUFA content of 20 % (P [ 0.001). A significant main effect diet was also observed for 16:0, but post hoc comparisons were not significant. Diabetic mice fed the Control diet exhibited no changes in any of the major individual fatty acids in brain; however, these mice did exhibited a 12 % increase in the percentage of total n-6 PUFA (P \ 0.05) compared to non-diabetic mice fed the Control diet.
In diabetic mice fed the High-fat diet, 22:5n-6 was increased roughly 250 % compared to either diabetic or non-diabetic mice fed the Control diet (P \ 0.001). This increase in 22:5n-6 was roughly half that produced by the High-fat diet in non-diabetic mice (P \ 0.001). In contrast NS not significant * Different from control diet, non-diabetic (P \ 0.05) Different from high-fat diet, non-diabetic (P \ 0.05) à Different for control diet, diabetic (P \ 0.05) by two-way ANOVA followed by Tukey's test comparing all four groups Lipids (2013) 48:939-948 943 to its effects in non-diabetic mice, the High-fat diet produced no change in 18:0 compared to diabetic mice fed the Control diet. The percentage total n-6 PUFA was increased 12 % (P \ 0.05) compared to normal mice fed the Control diet; however, they were not different from those of diabetic mice fed the High-fat diet.
Discussion
The effects of a high-fat diet and its interactions with STZinduced hyperglycemia with hypoinsulinemia on liver and brain total phospholipid fatty acid composition were examined in mice. The High-fat diet or diabetes produced a numerous changes in liver fatty acid composition and fewer alterations of smaller magnitude in brain fatty acid composition. Hyperglycemia with hypoinsulinemia partially attenuated the effects of a high-fat diet in both tissues.
Effects in the Liver
In non-diabetic mice, the high-fat diet resulted in a number of alterations in hepatic phospholipid fatty acid composition (Table 2) . Of perhaps greatest consequence were changes in PUFA with known functional activities including a modest increase in ARA (21 %) and a substantial decrease in DHA (68 %). Docosapentaenoic acid (DPAn-6, 22:5n-6) was also dramatically increased (985 %), most likely as a compensatory mechanism resulting from the change in DHA [43] . The net effect of these changes in individual fatty acids was significant changes in the n-3:n-6 and DHA:ARA ratios which have been previously shown to affect hepatic function (see below). The High-fat diet also decreased the ratio of 18:3n-3 to 18:2n-6, suggesting a decrease in D6-desaturase activity. Insulin stimulates the activities of both D5-and D6-desaturases by inducing expression of FADS1 and FADS2 [44, 45] , suggesting that some insulin-resistance may be occurring in the mice fed the High-fat diet. In addition, the High-fat diet increased the ratio of 18:1n-9 to 18:0, consistent with increased stearoyl-CoA desaturase-1 activity. Expression of stearoyl-CoA desaturase-1 is stimulated by insulin, and increased expression and activity of the enzyme are also associated with insulin resistance [45] [46] [47] . These findings have both similarities and differences with other studies of the effects of high-fat diets in rodents. In a study in which pregnant and nursing rat dams were fed a high-fat diet (33 % by weight lard-based), similar changes in DHA and ARA were observed in the pups at postnatal day 15. The dams also exhibited increases in the percentages of ARA and DPAn-6, however, hepatic DHA content was not decreased [48] . Another study in rats fed a linseed oil-based high-fat diet (13 % by weight) for 20 days found decreases in both ARA and DHA in male rats compared to controls, whereas female rats fed the high-fat diet exhibited only a decrease in hepatic ARA content [49] . In contrast, yet another study in which rats were fed a 30 % by weight coconut oil-based diet for 20 weeks resulted in decreased 16:0, 18:1 and ARA and increased 18:0, 18:2n-6, and DHA [50] . These finding suggest sex and species differences in the regulation of hepatic fatty acid composition, as well as differential effects of specific diets. Streptozotocin-induced diabetes resulted in an increase in the percentage of 16:0 and a decrease in ARA in hepatic phospholipids. Diabetes also produced a main effect of increasing the ratio of 20:4n-6 to 20:3n-6, suggesting an increase in D5-desaturase activity. Although the effects of STZ-induced diabetes on liver fatty acid composition varies between studies, decreased ARA content is highly consistent between studies and has also been reported in the Zucker rats and ob/ob mouse models of type 2 diabetes [48, [51] [52] [53] [54] [55] [56] [57] . Several of these studies with STZ-treated rats or ob/ob mice also found increases in the percentage of 18:0 and/or 18:1 and DHA [48, [51] [52] [53] 57] , which were not observed in this study and may reflect species differences and differences between type 1 and type 2 diabetes models. Likewise, other studies indicate lower D5-and D6-desaturases and stearoyl-CoA desaturase-1 activities with reduced insulin levels [44] [45] [46] , which were not observed in this study.
Feeding the high-fat diet in STZ-induced diabetic mice resulted in changes in hepatic fatty acid composition that were qualitatively similar to those observed in non-diabetic mice fed the high-diet; however, the magnitude of the changes was smaller for all affected fatty acids except ARA, as well as on the ratio of fatty acids indicative of stearoyl-CoA desaturase-1 activity. This suggests that in this model, the physiological effects of hypoinsulinemia, which results in effects such as excess glucagon secretion and increased production of glucose and lipid-derived ketones by the liver [58] , attenuates at least some of the hepatic effects of the high-fat diet.
Variation in hepatic phospholipid composition has been shown to affect liver function. In hepatocytes, changes in the ratio of ARA:DHA altered expression of genes encoding a variety of proteins including several cytochromes P-450 [59] [60] [61] . In vivo, altered relationship between ARA and DHA, induced by dietary manipulations, resulted in changes in hepatic expression of genes encoding numerous proteins such as cytochromes P-450 and peroxidases, and proteins involved in heme synthesis and utilization, bile acid metabolism, lipid synthesis and transport, and lipoprotein metabolism [62] [63] [64] [65] . These changes in gene expression likely contribute to the changes in lipid metabolism and glucose regulation associated with consumption of a high-fat diet and/or diabetes. In addition, manipulation of total fat and n-3:n-6 ratios resulted in altered levels of a variety of eicosanoids including a variety of leukotrienes and prostacyclins [66] . Consistent with these observations, high dietary fat content was associated with hepatic inflammation in non-alcoholic fatty liver disease [67] . Thus, changes in liver fatty acid composition resulting most notably from consuming a high-fat diet likely affects numerous aspects of hepatic function.
Effects in the Brain
Compared to the liver, there has been relatively limited investigation of the effects of a high-fat diet or diabetes on the fatty acid composition of the brain. Consistent with the slow response of the brain to dietary manipulations, which likely reflects the slower turnover of phospholipids in that tissue [39] , the magnitude of the changes in fatty acid composition in brain were smaller than those observed in the liver after 8 weeks of dietary manipulation and/or experimentally-induced diabetes. Accordingly, future studies must determine whether additional changes in brain fatty acid composition or changes of greater magnitude might be observed with a longer duration of treatment.
In mice fed the high-fat diet, the percentages of ARA and DPAn-6 were increased, similar to the effect in liver (Table 3) . In contrast to the liver, the percentage of DHA was not altered, resulting in no significant difference in the n-3:n-6 ratio. Also in contrast with the liver, the high-fat diet resulted in an increase in 18:0 (8 %) in the brain. Interestingly, these findings differ from those produced by a lard-based high-fat diet (19 % by weight) fed from conception through 9 weeks of age in female C57BL/6j mice, which resulted in a decrease in brain DHA of roughly 50 % and increases in 16:0 and 18:0 [68] . Thus, the effects of a high saturated fat diet may have different effects in the developing and mature brain.
In contrast to effects of the high-fat diet, STZ-induced diabetes did not alter the percentage of any of the abundant species of individual fatty acids in brain, though a small increase in total n-6 PUFA was detected (12 %). A similar lack of effect has been reported in STZ-treated rats [55] . Likewise, no changes in brain fatty acid composition were observed in female Zucker rats [56] . However, other studies with STZ-induced diabetes in rats reported decreases in ARA [51] [52] [53] , and one also observed a decrease in DHA [51] . Thus, as with the liver, these differences likely reflect species variation, as well as differences between diabetes models.
Also consistent with the effects observed in the liver, STZ-induced diabetes partially attenuated the effects of the High-fat diet on brain fatty acid composition. Notably, the only individual fatty acid that was significantly different between diabetic mice fed the Control and High-fat diets was DPAn-6. DPAn-6 was increased 273 % in the diabetic mice fed the High-fat diet; however, this increase was significantly smaller than the 645 % increase produced the High-fat diet in non-diabetic mice.
The changes in brain fatty acid composition induced by the high-fat diet have several potential functional consequences. Metabolic syndrome has been shown to have significant comorbidity with depression [9] Consistent with the increased percentage of brain ARA observed in this study, high-fat diets have been shown to increase indices of inflammation in brain, an emerging component in the pathophysiology of depression [69] , such as lipid peroxidation [70] . High-fat diets have also been shown to induce depression-like behavior in mice [71] , and to impair hippocampal neurogenesis through a mechanism involving decreased hippocampal brain-derived neurotrophic factor [70, 72] , both of which are observed in depressed patients [73] . Alterations in brain phospholipid fatty acid composition, notably decreased DHA, are also reported in depression [36, 74] . Decreases in tissue DHA content are typically associated with a concomitant increase in DPAn-6, which is thought to result from the compensatory substitution of 22-carbon n-6 PUFA for the 22-carbon n-3 PUFA [41, 43] . Interestingly, in this study, a dramatic increase in DPAn-6 content was observed in the absence of a change in DHA, raising the possibility that incorporation of DHA and DPAn-6 into phospholipids may be differentially regulated.
High-fat diets and insulin resistance are also associated with Alzheimer's disease [16] . In animal studies, high-fat diets have been shown to result in impaired cognitive function and decreased hippocampal plasticity [75] [76] [77] . Alzheimer's disease is also associated with altered brain fatty acid composition, most consistently decreased ARA (20:4n-6) and stearic acid (18:0) [34, 35] . The brain fatty acid changes observed in mice fed a high-fat diet and/or with STZ-induced diabetes did not recapitulate the changes observed in Alzheimer's disease. This suggests that the metabolic pathology in Alzheimer's disease cannot be attributed simply to high dietary fat intake, high blood glucose with hypoinsulinemia, or the interaction of these factors.
Conclusion
A high-fat diet or STZ-induced diabetes produced substantial changes in liver phospholipid fatty acid composition and smaller and more limited changes in brain fatty acid composition. These changes include increases in ARA, and may thus result in increased inflammatory tone. Interestingly, the effects of the high-fat diet were of smaller magnitude in diabetic mice compared to non-diabetic mice, suggesting that the apparently additive effects of a high-fat diet and diabetes on diabetic complications such as peripheral vascular disease and neuropathy, may not result from augmented changes in tissue fatty acid composition. Furthermore, the observed changes in brain do not recapitulate fatty acid alterations observed in depression or Alzheimer's disease.
